Vascular impairment of erection in patients with diabetes and Peyronie's disease: Is that accumulative?

Journal of Sexual Medicine

Volumn 6, Issue 6, 2009, Pages 1736-1742

  El Sakka, Ahmed I ^a,c   Tayeb, Khaled A ^b  

^a Suez Canal University Faculty of Medicine   (Egypt)

^b AL NOOR SPECIALIST HOSPITAL   (Saudi Arabia)

^c NONE   (Egypt)

Author keywords

Diabetes mellitus; Erectile dysfunction; Peyronie's disease

Indexed keywords

HEMOGLOBIN A1C;

ADULT; ARTICLE; BLOOD FLOW VELOCITY; BODY MASS; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COLOR ULTRASOUND FLOWMETRY; COMORBIDITY; DISEASE SEVERITY; DYSLIPIDEMIA; ERECTILE DYSFUNCTION; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HEMODYNAMIC PARAMETERS; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; INTERVIEW; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PEYRONIE DISEASE; PRIORITY JOURNAL; RISK FACTOR; SMOKING;

EID: 66649117736     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2009.01243.x     Document Type: Article

References (32)

1. Lopez JA, Jarow JP. Penile vascular evaluation of men with Peyronie's disease. J Urol 1993;149:53-5.
2. Mulhall JP, Creech SD, Boorjian SA, Ghaly S, Kim ED, Moty A, Davis R, Hellstorm W. Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screening. J Urol 2004;171:2350-3.
3. Montorsi F, Guazzoni G, Bergamaschi F, Consonni P, Rigatti P, Pizzini G, Miani A. Vascular abnormalities in Peyronie's disease: The role of color Doppler sonography. J Urol 1994;151:373-5.
4. Devine CJ, Jr., Horton CE. Peyronie's disease. Clin Plast Surg 1988;15:405-9.
5. El-Sakka AI, Hassoba HM, Pillarisetty RJ, Dahiya R, Lue TF. Peyronie's disease is associated with an increase in transforming growth factor-beta protein expression. J Urol 1997;158:1391-4.
6. Bivalacqua TJ, Champion HC, Leungwattanakij S, Yang DY, Hyun JS, Abdel-Mageed AB, Sikka SC, Kadowitz PJ, Hellstrom WJ. Evaluation of nitric oxide synthase and arginase in the induction of a Peyronie's-like condition in the rat. J Androl 2001;22:497-506.
7. Moreland RB, Nehra A. Pathophysiology of Peyronie's disease. Int J Impot Res 2002;14:406-10.
8. Cantini LP, Ferrini MG, Vernet D, Magee TR, Qian A, Gelfand RA, Rajfer J, Gonzalez-Cadavid NF. Profibrotic role of myostatin in Peyronie's disease. J Sex Med 2008;5:1607-22.
9. Saenz de Tejada I, Goldstein I. Diabetic penile neuropathy. Urol Clin North Am 1988;15:17.
10. Sharma K, Ziyadeh FN. Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator. Diabetes 1995;44:1139-46.
11. Zhang LW, Piao S, Choi MJ, Shin HY, Jin HR, Kim WJ, Song SU, Han JY, Park SH, Mamura M, Kim SJ, Ryu JK, Suh JK. Role of increased penile expression of transforming growth factor-beta1 and activation of the Smad signaling pathway in erectile dysfunction in streptozotocin-induced diabetic rats. J Sex Med 2008;5:2318-29.
12. Mogyorosi A, Ziyadeh FN. Increased decorin mRNA in diabetic mouse kidney and in mesengial and tubuler cells cultured in high glucose. Am J Physiol 1998;275:F827-32.
13. Kadioglu A, Tefekli A, Erol B, Oktar T, Tunc M, Tellaloglu S. Retrospective review of 307 men with Peyronie's disease. J Urol 2002;168:1075-9.
14. El-Sakka AI, Tayeb KA. Peyronie's disease in diabetic patients being screened for erectile dysfunction. J Urol 2005;174:1026-30.
15. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Peña BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999;11:319-26.
16. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-53.
17. Donatucci CF, Lue TF. The combined intracavernous injection and stimulation test: Diagnostic accuracy. J Urol 1992;148:61-2.
18. El-Sakka AI, Morsy AM. Screening for ischemic heart disease in patients with erectile dysfunction: Role of penile Doppler ultrasonography. Urology 2004;64:346-50.
19. El-Sakka AI, Lin CS, Chui RM, Dahiya R, Lue TF. Effects of diabetes on nitric oxide synthase and growth factor genes and protein expression in an animal model. Int J Impot Res 1999;11:123.
20. Penson DF, Latini DM, Lubeck DP, Wallace KL, Henning JM, Lue TF; Comprehensive Evaluation of Erectile Dysfunction (ExCEED) database. Do impotent men with diabetes have more severe erectile dysfunction and worse quality of life than the general population of impotent patients? Results from the Exploratory Comprehensive Evaluation of Erectile Dysfunction (ExCEED) database. Diabetes Care 2003;26:1093-9.
21. Rhoden EL, Teloken C, Ting HY, Lucas ML, Teodosio da Ros C, Ary Vargas Souto C. Prevalence of Peyronie's disease in men over 50-y-old from Southern Brazil. Int J Impot Res 2001;13:291-3.
22. El-Sakka AI. Prevalence of Peyronie's disease among patients with erectile dysfunction. Eur Urol 2006;49:564-9.
23. Pescatori ES, Hatzichristou DG, Namburi S, Goldstein I. A positive intracavernous injection test implies normal veno-occlusive but not necessarily normal arterial function: A hemodynamic study. J Urol 1994;151:1209-16.
24. La Pera G, Pescatori ES, Calabrese M, Boffini A, Colombo F, Andriani E, Natali A, Vaggi L, Catuogno C, Giustini M, Taggi F; SIMONA Study Group. Peyronie's disease: Prevalence and association with cigarette smoking. A multicenter population-based study in men aged 50-69 years. Eur Urol 2001;40:525-30.
25. Lue TF, Hricak H, Marich KW, Tanagho EAI. Vasculogenic impotence evaluated by high-resolution ultrasonography and pulsed Doppler spectrum analysis. Radiology 1985;155:777-81.
26. Wilkins CJ, Sriprasad S, Sidhu PS. Color Doppler ultrasound of the penis. Clin Radiol 2004;58:514-23.
27. Usta MF, Bivalacqua TJ, Tokatli Z, Rivera F, Gulkesen KH, Sikka SC, Hellstrom WJ. Stratification of penile vascular pathologies in patients with Peyronie's disease and in men with erectile dysfunction according to age: A comparative study. J Urol 2004;172:259-62.
28. Seftel AD, Vaziri ND, Ni Z, Razmjouei K, Fogarty J, Hampel N, Polak J, Wang RZ, Ferguson K, Block C, Haas C. Advanced glycation end products in human penis: Elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS. 1997;50:1016-26.
29. Chen S, Jim B, Ziyadeh FN. Diabetic nephropathy and transforming growth factor-beta: Transforming our view of glomerulosclerosis and fibrosis build-up. Semin Nephrol 2003;23:532-43.
30. Baricos WH, Cortez SL, Deboisblanc M, Xin S. Transforming growth factor-beta is a potent inhibitor of extracellular matrix degradation by cultured human mesangial cells. J Am Soc Nephrol 1999;10:790-5.
31. Burke FD, Proud G, Lawson IJ, McGeoch KL, Miles JN. An assessment of the effects of exposure to vibration, smoking, alcohol and diabetes on the prevalence of Dupuytren's disease in 97,537 miners. J Hand Surg Eur Vol 2007;32:400-6.
32. Kendirci M, Trost L, Sikka SC, Hellstrom WJ. Diabetes mellitus is associated with severe Peyronie's disease. BJU Int 2007;99:383-6.